Welcome to the e-CCO Library!

P303: Ultrasound is effective to identify mucosal healing in Crohn's disease patients : results of a cross-sectional study
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Yzet, C.(1);Brazier, F.(1);Hautefeuille, V.(1);Decrombecque, C.(1);Sarba, R.(1);aygalenq, P.(2);Venezia, F.(3);Buisson, A.(4);Pichois, R.(5);Michaud, A.(6);Fumery, M.(1)*;
Created: Friday, 14 July 2023, 11:05 AM
P304 Extranodal primary intestinal lymphoma in inflammatory bowel disease: An ECCO CONFER multi-centre case series
Year: 2020
Source:

ECCO'20 Vienna

Authors:

F. Phillips1, B. Verstockt2,3, D. Ribaldone4, I. Guerra5, N. Teich6, K. Katsanos7, R. Filip8, T. Molner9, K. Karmiris10, ECCO CONFER Investigators

Created: Thursday, 30 January 2020, 10:12 AM
P304: Faecal calprotectin as surrogate marker of transmural healing assessed using MRI in patients with Crohn’s disease
Year: 2018
Source: ECCO '18 Vienna
Authors:

C. Allimant1*, L. Messadeg2, R. Minet Quinard3, M. Goutte1,4, D. Bouvier3, F. Goutorbe1,5, B. Pereira6, G. Bommelaer1,4, C. Hordonneau2, A. Buisson1,4

Created: Thursday, 21 February 2019, 9:14 AM
P304: Intensified versus conventional infliximab induction in acute severe steroid-refractory Ulcerative Colitis
Year: 2022
Source: ECCO'22
Authors: Pedro, J.(1);Coelho Rodrigues, I.(1);Botto, I.(1);Fernandes, S.(1);Bernardo, S.(1);Gonçalves, A.R.(1);Moura Santos, P.(1);Valente, A.(1);Correia, L.(1);Tato Marinho, R.(1);
Created: Friday, 11 February 2022, 3:52 PM
P304: Leucine-rich alpha 2 glycoprotein reduces the necessity for endoscopic examination for activity evaluation
Year: 2023
Source: ECCO’23 Copenhagen
Authors: HayashiHayasix@0917, T.(1)*;Takatori, H.(1);Yamashita, T.(1);
Created: Friday, 14 July 2023, 11:05 AM
P304: Patients with perianal Crohn’s disease have poor disease outcomes after primary bowel resection
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

Y. M. Han*1, J. W. Kim2, J. H. Kim1, S.-J. Koh2, H. Yoon3, C. Lee4, J. P. Im1, J. S. Kim1

Created: Friday, 22 February 2019, 9:49 AM
P304: Predicting severity in Crohn's disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

C. Gouveia*1, C. Gomes1, L. Glória1, J. Torres1, M. Cravo2

Created: Friday, 22 February 2019, 9:41 AM
P304: Rational infliximab induction dosing to achieve long-term deep remission in children with Inflammatory Bowel Diseases
Year: 2021
Source: ECCO'21 Virtual
Authors: Kantasiripitak, W.(1);van Hoeve, K.(2);Sabino, J.(3,4);Vermeire, S.(3,4);Hoffman, I.(2);Declerck, P.(1);Thomas, D.(1);Ferrante, M.(3,4);Dreesen, E.(1,5);
Created: Wednesday, 2 June 2021, 4:12 PM
P304: Zinc levels, interplay with ATG16L1 and disease outcome in Crohn's disease patients in the Swiss IBD cohort study
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Greuter T.*1, Franc Y.2, Kaelin M.3, Schoepfer A.4, Misselwitz B.1, Vavricka S.1,5, Rogler G.1, Biedermann L.1

Created: Wednesday, 20 February 2019, 10:36 AM
P305 A location-based prediction model in Crohn’s disease regarding a novel serological marker, anti-Chitinase 3-like 1 autoantibodies
Year: 2020
Source:

ECCO'20 Vienna

Authors:

N. Sipeki MD1, P. Kovats1, C. Deutschmann2, P. Schierack2, D. Roggenbuck2, P. Maria1

Created: Thursday, 30 January 2020, 10:12 AM
P305: Effectiveness and Safety of Vedolizumab in Biologic-Naïve Patients: Real-World Data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD)
Year: 2021
Source: ECCO'21 Virtual
Authors: Macaluso, F.(1);Fries, W.(2);Renna, S.(1);Viola, A.(2);Muscianisi, M.(2);Cappello, M.(3);Guida, L.(3);Siringo, S.(4);Camilleri, S.(5);Garufi, S.(5);Privitera, A.C.(6);Belluardo, N.(7);Giangreco, E.(7);Bertolami, C.(8);Vassallo, R.(9);Rizzuto, G.(1);Orlando, R.(1);Ventimiglia, M.(1);Orlando, A.(1);
Created: Wednesday, 2 June 2021, 4:12 PM
P305: Indirect comparison of two novel biologics for the treatment of Crohn's disease : network-meta analysis of ustekinumab vs vedolizumab
Year: 2017
Source: ECCO '17 Barcelona
Authors:

Hather G.1, Curtis R.2, Minda K.2, Zouraq I.A.3, Khalid J.M.*4

Created: Wednesday, 20 February 2019, 10:36 AM
P305: Intra-cavitary contrast-enhanced ultrasound: A novel radiation-free method to detect abscess associated internal fistulas in Crohn’s disease
Year: 2018
Source: ECCO '18 Vienna
Authors:

R. Mao1*, Y.-j. Chen1, J. Rimola2, F. Rieder3, S. Ben-Horin4, M.-h. Chen1, X.-y. Xie1

Created: Thursday, 21 February 2019, 9:14 AM
P305: Low ALT is more Common in Patients with IBD than Healthy Controls and is Associated with Active Disease
Year: 2022
Source: ECCO'22
Authors: Shafrir, A.(1,2,3);Katz, L.(1,2);Zinger, A.(1,2);Safadi, R.(1,2);Kaliski, I.(1,2);
Created: Friday, 11 February 2022, 3:52 PM
P305: No increased risk for infections with thiopurine-induced leukopenia in inflammatory bowel disease patients without a variant in thiopurine S-methyltransferase
Year: 2016
Source: ECCO '16 Amsterdam
Authors:

M. Broekman*1, M. Coenen2, C. van Marrewijk2, G. Wanten1, L. Derijks3, S. Vermeulen2, 4, D. Wong5, O. Klungel6, A. Verbeek4, P. Hooymans5, H. Scheffer2, H.-J. Guchelaar7, D. de Jong1

Created: Friday, 22 February 2019, 9:49 AM
P305: Normal reference ranges and cut-off values for considering and performing endoscopy using the Sentinel CaliaGold® Calprotectin assay
Year: 2023
Source: ECCO’23 Copenhagen
Authors: Schoorl, M.(1)*;Beugelink, T.(1);Grasman, M.E.(2);Jongbloed, W.(1);
Created: Friday, 14 July 2023, 11:05 AM
P305: Platelet parameters evaluation as a non-invasive marker of inflammation in Crohn’s disease
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

M. Padysz*1, J. Banasik1, A. Gąsiorowska1

Created: Friday, 22 February 2019, 9:41 AM
P306 Frequency and structure of extra-intestinal manifestations in IBD
Year: 2020
Source:

ECCO'20 Vienna

Authors:

M. Skalinskaya, E. Skazyvaeva, I. Bakulin, I. Rasmagina, D. Komarova, K. Ivanova

Created: Thursday, 30 January 2020, 10:12 AM
P306: Double balloon enteroscopy in paediatric Crohn’s disease and 10 years follow-up
Year: 2019
Source:

ECCO '19 Copenhagen

Authors:

J. Oba*1,2, A. Carlos3, M. Azevedo3, L. Milani3, N. Freitas4, R. Toma5, M. Bibas5, A. Damião3, A. Safatle-Ribeiro3

Created: Friday, 22 February 2019, 9:41 AM
P306: Efficacy and tolerance of sodium picosulfate preparation in bowel Magnetic Resonance Imaging in Crohn’s disease
Year: 2022
Source: ECCO'22
Authors: Juif, L.(1);Calame, P.(1);Chausset, C.(1);Koch, S.(1);Briot, C.(2);De Billy, M.(1);Vuitton, L.(1);
Created: Friday, 11 February 2022, 3:52 PM